The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2
Open accessAbstract
CLEC-2 has been described recently as playing crucial roles in thrombosis/hemostasis, tumor metastasis, and lymphangiogenesis. The snake venom rhodocytin is known as a strong platelet activator, and we have shown that this effect is mediated by CLEC-2 (Suzuki-Inoue, K., Fuller, G. L., García, A., Eble, J. A., Pöhlmann, S., Inoue, O., Gartner, T. K., Hughan, S. C., Pearce, A. C., Laing, G. D., Theakston, R. D., Schweighoffer, E., Zitzmann, N., Morita, T., Tybulewicz, V. L., Ozaki, Y., and Watson, S. P. (2006) Blood 107, 542-549). Podoplanin, which is expressed on the surface of tumor cells, is an endogenous ligand for CLEC-2 and facilitates tumor metastasis by inducing platelet aggregation. Mice deficient in podoplanin, which is also expressed on the surface of lymphatic endothelial cells, show abnormal patterns of lymphatic vessel formation. In this study, we report on the generation and phenotype of CLEC-2-deficient mice. These mice are lethal at the embryonic/neonatal stages associated with disorganized and blood-filled lymphatic vessels and severe edema. Moreover, by transplantation of fetal liver cells from Clec-2(-/-) or Clec-2(+/+) embryos, we were able to demonstrate that CLEC-2 is involved in thrombus stabilization in vitro and in vivo, possibly through homophilic interactions without apparent increase in bleeding tendency. We propose that CLEC-2 could be an ideal novel target protein for an anti-platelet drug, which inhibits pathological thrombus formation but not physiological hemostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platelet-collagen interaction: is GPVI the central receptor?
Nieswandt, B., & Watson, S. P. (2003) · Blood · doi:10.1182/blood-2002-12-3882 · Cited by 1,150
T1 /podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema
Schacht, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg342 · Cited by 653
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
Turner, M., Joseph Mee, P., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L., & Tybulewicz, V. L. J. (1995) · Nature · doi:10.1038/378298a0 · Cited by 612
Schacht, V., Dadras, S. S., Johnson, L. A., Jackson, D. G., Hong, Y.-K., & Detmar, M. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62311-5 · Cited by 596
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
Suzuki-Inoue, K. (2006) · Blood · doi:10.1182/blood-2005-05-1994 · Cited by 523
Self-citationSuzuki-Inoue, K., Kato, Y., Inoue, O., Kaneko, M. K., Mishima, K., Yatomi, Y., Yamazaki, Y., Narimatsu, H., & Ozaki, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702327200 · Cited by 519
Self-citationBreiteneder-Geleff, S., Matsui, K., Soleiman, A., Meraner, P., Poczewski, H., Kalt, R., Schäffner, G., & Kerjaschki, D. (1997) · Europe PMC (PubMed Central) · Cited by 495
Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk
Abtahian, F., Guerriero, A., Sebzda, E., Lu, M.-M., Zhou, R., Mocsai, A., Myers, E. E., Huang, B., Jackson, D. G., Ferrari, V. A., et al. (2003) · Science · doi:10.1126/science.1079477 · Cited by 421
Law, D. A., DeGuzman, F. R., Heiser, P., Ministri-Madrid, K., Killeen, N., & Phillips, D. R. (1999) · Nature · doi:10.1038/44599 · Cited by 325
Uhrin, P., Zaujec, J., Breuss, J. M., Olcaydu, D., Chrenek, P., Stockinger, H., Fuertbauer, E., Moser, M., Haiko, P., Fässler, R., et al. (2010) · Blood · doi:10.1182/blood-2009-04-216069 · Cited by 297
Cited by
Signaling by Myeloid C-Type Lectin Receptors in Immunity and Homeostasis
Sancho, D., & Reis e Sousa, C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101352 · Cited by 520
Podoplanin: emerging functions in development, the immune system, and cancer
Astarita, J. L., Acton, S. E., & Turley, S. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00283 · Cited by 402
Lymphatic vascular morphogenesis in development, physiology, and disease
Schulte-Merker, S., Sabine, A., & Petrova, T. V. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201012094 · Cited by 394
New Concepts and Mechanisms of Platelet Activation Signaling
Estevez, B., & Du, X. (2017) · Physiology · doi:10.1152/physiol.00020.2016 · Cited by 376
Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke
NIESWANDT, B., PLEINES, I., & BENDER, M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04361.x · Cited by 356
Functional significance of the platelet immune receptors GPVI and CLEC-2
Rayes, J., Watson, S. P., & Nieswandt, B. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122955 · Cited by 328
Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum
Vieira-de-Abreu, A., Campbell, R. A., Weyrich, A. S., & Zimmerman, G. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0286-4 · Cited by 321
Acton, S. E., Astarita, J. L., Malhotra, D., Lukacs-Kornek, V., Franz, B., Hess, P. R., Jakus, Z., Kuligowski, M., Fletcher, A. L., Elpek, K. G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.022 · Cited by 318
How platelets safeguard vascular integrity
HO‐TIN‐NOÉ, B., DEMERS, M., & WAGNER, D. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04317.x · Cited by 271
Syk-coupled C-type lectins in immunity
Kerrigan, A. M., & Brown, G. D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.002 · Cited by 170
Metadata
- Authors
- Suzuki-Inoue, K., Inoue, O., Ding, G., Nishimura, S., Hokamura, K., Eto, K., Kashiwagi, H., Tomiyama, Y., Yatomi, Y., Umemura, K., Shin, Y., Hirashima, M., & Ozaki, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 285
- Issue
- 32
- Pages
- 24494-24507
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2038336599
- Cited by
- 266
- References
- 31
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.